Chronobiology in Management of Bipolar Disorders: What We Know So Far?
DOI:
https://doi.org/10.51338/rppsm.251Keywords:
Bipolar Disorder, Chronobiology, Circadian RhythmAbstract
.
Downloads
Download data is not yet available.
References
(1) Steardo, L., Filippis, R., Carbone, E., Segura-Garcia, C., Verhratsky, A., & P., F. (2019). Sleep Disturbance in Bipolar Disorder: Neuroglia and Circadian Rhythms. Frontiers in Psychiatry , 10 (501), 1-12.
(2) Steinan, MT., Krane-Gartiser, K., Langsrud, K., Sand, T., Kallestand, H., Morken, G. (2014). Cognitive behavioral therapy for insomnia in euthymic bipolar disorder: study protocol for a randomized controlled trial. Trials. 16: 15-24.
(3) Harvey, AG., Soehner, AM., Kaplan KA., Hein, K., Lee, J., Kanady, J., Rabe-Hesketh, S., Neylan TC., Li, D., Ketter, TA., Buysse, DJ. (2015). Treating Insomnia Improves Mood State, Sleep, and Functioning in Bipolar Disorder: A Pilot Randomized Controlled Trial. Journal of Consulting and Clinical Psychology. 83(3):564-577.
(4) Macedo, E., Silva, CF. (2015). Ritmos Sociais e Volume de Atividade Social de Pessoas em Programa de Substituição com Metadona. Revista Portuguesa de Enfermagem de Saúde Mental. 2:78-83.
(5) Bottai, T., Biloa-Tang, M., Christophe, S., Dupuy, C., Jacquesy, L., Kochman, F., Meynard, JA., Papeta, D., Rahioui, H., Adida, M., Fakra, E., Kaladjian, A., Pringuey, D., Azorin, JM. (2010) Interpersonal and social rhythm therapy. L’Encephale. 6:S206-17.
(6) Bouwkamp, CG., Kruiff, ME., Troost, TM., Snippe, D., Blom, MJ., Winter, RFP., Haffmans, PMJ. (2013). Interpersonal and social rhythm group therapy for patients with bipolar disorder. International Journal of Group Psychotherapy.
(7) Frank, E., Kupfer, DJ., Thase, ME., Mallinger, AG., Swartz, HA., Fagiolini, AM., Grochocinski, V., Houck, P., Scott, J., Thompson, W., Monk, T. (2005). Two-year outcomes for interpersonal and social rhythm therapy in individuals with bipolar I disorder. Archives of General Psychiatry. 62(9):996-1004.
(8) Esaki, Y., Takeuchi, I., Tsuboi, S., Fujita, K., Iwata, N., Kitajima. (2020). A double-blind, randomized, placebo-controlled trial of adjunctive blue-blocking glasses for the treatment of sleep and circadian rhythm in patients with bipolar disorder. Bipolar Disorders. 22(7): 739-748.
(9) Henriksen, TE., Skrede, S., Fasmer, OB., Schoeyen, H., Leskauskaite, I., Bjorke-Bertheussen, J., Assmus, J., Hamre, B., Gronli, J., Lund, A. (2016). Blue-blocking glasses as additive treatment for mania: a randomized placebo-controlled trial. Bipolar Disorders. 18(3): 221-32.
(10) Moghaddam, HS., Bahamani, S., Bayanati, S., Mahdavinasa, M., Rezaei, F., Akhondzadedh, S. (2020). Efficacy of melatonin as an adjuvante in the treatment of acute mania: a double-blind and placebo-controlled trial. International Clinical Psicopharmacology. 35(2): 81-88.
(11) Souza LC, Wilhelm EA, Bortolatto CF, Nogueira CW, Boeira SP, Jesse CR (2014). The protective effect of melatonin against brain oxidative stress and hyperlocomotion in a rat model of mania induced by ouabain. Behav Brain Res 271:316–324.
(12) Kirshenbaum GS, Burgess CR, Déry N, Fahnestock M, Peever JH, Roder JC (2014). Attenuation of mania-like behavior in Na(+), K(+)-atpase α3 mutant mice by prospective therapies for bipolar disorder: melatonin and exercise. Neuroscience 260:195–204.
(2) Steinan, MT., Krane-Gartiser, K., Langsrud, K., Sand, T., Kallestand, H., Morken, G. (2014). Cognitive behavioral therapy for insomnia in euthymic bipolar disorder: study protocol for a randomized controlled trial. Trials. 16: 15-24.
(3) Harvey, AG., Soehner, AM., Kaplan KA., Hein, K., Lee, J., Kanady, J., Rabe-Hesketh, S., Neylan TC., Li, D., Ketter, TA., Buysse, DJ. (2015). Treating Insomnia Improves Mood State, Sleep, and Functioning in Bipolar Disorder: A Pilot Randomized Controlled Trial. Journal of Consulting and Clinical Psychology. 83(3):564-577.
(4) Macedo, E., Silva, CF. (2015). Ritmos Sociais e Volume de Atividade Social de Pessoas em Programa de Substituição com Metadona. Revista Portuguesa de Enfermagem de Saúde Mental. 2:78-83.
(5) Bottai, T., Biloa-Tang, M., Christophe, S., Dupuy, C., Jacquesy, L., Kochman, F., Meynard, JA., Papeta, D., Rahioui, H., Adida, M., Fakra, E., Kaladjian, A., Pringuey, D., Azorin, JM. (2010) Interpersonal and social rhythm therapy. L’Encephale. 6:S206-17.
(6) Bouwkamp, CG., Kruiff, ME., Troost, TM., Snippe, D., Blom, MJ., Winter, RFP., Haffmans, PMJ. (2013). Interpersonal and social rhythm group therapy for patients with bipolar disorder. International Journal of Group Psychotherapy.
(7) Frank, E., Kupfer, DJ., Thase, ME., Mallinger, AG., Swartz, HA., Fagiolini, AM., Grochocinski, V., Houck, P., Scott, J., Thompson, W., Monk, T. (2005). Two-year outcomes for interpersonal and social rhythm therapy in individuals with bipolar I disorder. Archives of General Psychiatry. 62(9):996-1004.
(8) Esaki, Y., Takeuchi, I., Tsuboi, S., Fujita, K., Iwata, N., Kitajima. (2020). A double-blind, randomized, placebo-controlled trial of adjunctive blue-blocking glasses for the treatment of sleep and circadian rhythm in patients with bipolar disorder. Bipolar Disorders. 22(7): 739-748.
(9) Henriksen, TE., Skrede, S., Fasmer, OB., Schoeyen, H., Leskauskaite, I., Bjorke-Bertheussen, J., Assmus, J., Hamre, B., Gronli, J., Lund, A. (2016). Blue-blocking glasses as additive treatment for mania: a randomized placebo-controlled trial. Bipolar Disorders. 18(3): 221-32.
(10) Moghaddam, HS., Bahamani, S., Bayanati, S., Mahdavinasa, M., Rezaei, F., Akhondzadedh, S. (2020). Efficacy of melatonin as an adjuvante in the treatment of acute mania: a double-blind and placebo-controlled trial. International Clinical Psicopharmacology. 35(2): 81-88.
(11) Souza LC, Wilhelm EA, Bortolatto CF, Nogueira CW, Boeira SP, Jesse CR (2014). The protective effect of melatonin against brain oxidative stress and hyperlocomotion in a rat model of mania induced by ouabain. Behav Brain Res 271:316–324.
(12) Kirshenbaum GS, Burgess CR, Déry N, Fahnestock M, Peever JH, Roder JC (2014). Attenuation of mania-like behavior in Na(+), K(+)-atpase α3 mutant mice by prospective therapies for bipolar disorder: melatonin and exercise. Neuroscience 260:195–204.
Downloads
Published
2021-11-28
How to Cite
Fraga, A. M., Moura, N., Quintão, A., Santos, C., Cintra, P., & Moutinho, A. (2021). Chronobiology in Management of Bipolar Disorders: What We Know So Far?. Revista Portuguesa De Psiquiatria E Saúde Mental, 7(4), 133–135. https://doi.org/10.51338/rppsm.251
Issue
Section
Letter to the editor
